Cetera Advisors LLC trimmed its holdings in Inspire Medical Systems (NASDAQ:INSP) by 8.2% in the first quarter, Holdings Channel reports. The institutional investor owned 4,500 shares of the company’s stock after selling 400 shares during the quarter. Cetera Advisors LLC’s holdings in Inspire Medical Systems were worth $253,000 at the end of the most recent reporting period.
Other institutional investors have also added to or reduced their stakes in the company. Columbus Circle Investors raised its holdings in Inspire Medical Systems by 8.0% during the 4th quarter. Columbus Circle Investors now owns 47,127 shares of the company’s stock worth $1,991,000 after purchasing an additional 3,494 shares during the last quarter. Hamilton Lane Advisors LLC bought a new stake in Inspire Medical Systems during the 4th quarter worth about $605,000. TD Asset Management Inc. bought a new stake in Inspire Medical Systems during the 4th quarter worth about $404,000. Monashee Investment Management LLC bought a new stake in Inspire Medical Systems during the 4th quarter worth about $4,310,000. Finally, Teachers Advisors LLC raised its holdings in Inspire Medical Systems by 10.0% during the 3rd quarter. Teachers Advisors LLC now owns 16,461 shares of the company’s stock worth $693,000 after purchasing an additional 1,497 shares during the last quarter.
Several analysts have weighed in on the company. Zacks Investment Research cut Inspire Medical Systems from a “buy” rating to a “hold” rating in a report on Saturday, May 11th. Dougherty & Co assumed coverage on Inspire Medical Systems in a report on Tuesday, February 5th. They set a “buy” rating and a $64.00 price objective for the company. One investment analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the company’s stock. Inspire Medical Systems presently has an average rating of “Hold” and a consensus target price of $43.56.
Shares of NASDAQ:INSP opened at $54.67 on Wednesday. Inspire Medical Systems has a 1-year low of $27.30 and a 1-year high of $64.34.
Inspire Medical Systems (NASDAQ:INSP) last announced its quarterly earnings data on Tuesday, May 7th. The company reported ($0.35) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.39) by $0.04. The firm had revenue of $16.30 million for the quarter, compared to the consensus estimate of $17.79 million. Inspire Medical Systems’s quarterly revenue was up 63.0% on a year-over-year basis.
Inspire Medical Systems Company Profile
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
Further Reading: Convertible Shares
Want to see what other hedge funds are holding INSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inspire Medical Systems (NASDAQ:INSP).
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.